Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents.
Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents.
复制标题
异黄酮、喹喔啉和羟吲哚家族抗血管生成剂的比较研究。
DOI:
10.1023/a:1021528628524
复制
发表时间:
2002
期刊:
影响因子:
9.8
通讯作者:
Moody,ChristopherJ
中科院分区:
文献类型:
--
作者:
Whatmore,JacquelineL;Swann,Elizabeth;Barraja,Paola;Newsome,JefferyJ;Bunderson,Melisa;Beall,HowardD;Tooke,JohnE;Moody,ChristopherJ
A study designed to compare the effects on VEGF-induced angiogenesis of a number of known anti-angiogenic agents together with some novel derivatives thereof was undertaken. Thus the isoflavone biochanin A1, indomethacin2, the 3-arylquinoxaline SU1433 and its derivatives3–6, the benzoic acid derivative7, the oxindoles SU54168and SU666811, together with their simpleN-benzyl derivatives9,10, and12were selected for study. Using anin vitroassay the compounds were evaluated for their ability to inhibit VEGF-induced angiogenesis in HUVECs, and the cytotoxicity of representative compounds was also studied in tumour cell lines using 24-h exposure. The results indicate that the SU compounds, SU1433, SU5416 and SU6668, are more potent inhibitors of VEGF-induced angiogenesis than indomethacin or the naturally occurring biochanin A, presumably because they inhibit VEGF receptor signalling. Blocking one of the phenolic OH groups of SU1433 reduced anti-angiogenic activity, as did blocking the NH groups of SU5416 and SU6668. Cytotoxicity studies indicate that none of the compounds examined exhibited cytotoxicity at anti-angiogenic concentrations.